Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
van der Velden, V H J, van der Sluijs-Geling, A, Gibson, B E S, te Marvelde, J G, Hoogeveen, P G, Hop, W C J, Wheatley, K, Bierings, M B, Schuurhuis, G J, de Graaf, S S NVolume:
24
Year:
2010
Language:
english
Pages:
8
DOI:
10.1038/leu.2010.153
File:
PDF, 453 KB
english, 2010